John Kim
6PUBLICATIONS
61CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 16, 2026
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.Kyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh
|Jan 09, 2026
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE).Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi
|Jul 14, 2025
Evaluation of drug-drug interaction potentials between JP-1366 and celecoxib using physiologically based pharmacokinetic modeling.Seung Chan Choi, John Kim, Hyeong-Seok Lim
|Sep 13, 2024
Population pharmacokinetic analysis of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in patients and healthy volunteers.Eunsol Yang, Inyoung Hwang, Sang Chun Ji
|Jul 08, 2024
Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis.Jung-Hwan Oh, Hyun-Soo Kim, Dae Young Cheung
|Jun 27, 2024
In Vitro Metabolism and Transport Characteristics of Zastaprazan.Min Seo Lee, Jihoon Lee, Minyoung Pang
Pageof 1
Frequent Collaborators
2 joint publications
Jun Kim
2 joint publications
Woo Chul Chung
2 joint publications
Hyun-Soo Kim
2 joint publications
Dae Young Cheung
2 joint publications
Hang Lak Lee
2 joint publications
Yu Kyung Cho
2 joint publications
Gwang Ha Kim
2 joint publications
Suck Chei Choi
1 joint publications
Jong-Jae Park
1 joint publications
Minyoung Pang
